The intricate mechanisms governing brain health and function have long been subjects of extensive investigation. Recent research has shed light on two pivotal systems, the glymphatic system and the endocannabinoid system, and their profound role within the central nervous system. The glymphatic system is a recently discovered waste clearance system within the brain that facilitates the efficient removal of toxic waste products and metabolites from the central nervous system. It relies on the unique properties of the brain’s extracellular space and is primarily driven by cerebrospinal fluid and glial cells. Conversely, the endocannabinoid system, a multifaceted signaling network, is intricately involved in diverse physiological processes and has been associated with modulating synaptic plasticity, nociception, affective states, appetite regulation, and immune responses. This scientific review delves into the intricate interconnections between these two systems, exploring their combined influence on brain health and disease. By elucidating the synergistic effects of glymphatic function and endocannabinoid signaling, this review aims to deepen our understanding of their implications for neurological disorders, immune responses, and cognitive well-being.

Childhood obesity linked to metabolic alterations, tend to appear simultaneously with altered adipocytokines. suggesting its role in pathogenesis development. Low circulating level of Total and High Molecular Weight adiponectin have been associated with components of the metabolic syndrome and could represent an independent risk factor with potential use as biomarker. To examine the prevalence of the metabolic syndrome in scholar children and to compare the degree of association of Total and High Molecular Weight adiponectin levels with biochemical parameters related to the metabolic syndrome. The study included a population of 155 boys and girls, from 8 to 11 years old. Anthropometric and biochemical parameters were evaluated according to weight and metabolic syndrome status. A correlation analysis was fitted to establish an association between adiponectin concentration and metabolic indicators. The prevalence of metabolic syndrome was of 10.3%. Impaired biochemical parameters, including Total and High Molecular Weight adiponectin, were associated with obesity. The adiponectin level was significantly lower in MS than in Non-MS subjects (4.5 vs. 5.4 μg/mL). Total- but no High Molecular Weight adiponectin concentration was negatively correlated with blood pressure, fasting insulin, and Homeostatic Model Assessment for Insulin Resistance. In young children, the Total-adiponectin level is associated with impaired biochemical parameters and could be an excellent early predictor of metabolic complications.

Caerulin-induced pancreatitis in rats: Histological and genetic expression changes from acute phase to recuperation